Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2020

01-09-2020 | Pancreatic Cancer | Brief Communication

Physical Inactivity and Pancreatic Cancer Mortality

Authors: Megha Pratapwar, Ashley E. Stenzel, Janine M. Joseph, Christos Fountzilas, John Lewis Etter, Jennifer M. Mongiovi, Rikki Cannioto, Kirsten B. Moysich

Published in: Journal of Gastrointestinal Cancer | Issue 3/2020

Login to get access

Abstract

Objective

To determine the association between pre-diagnostic recreational physical inactivity (RPI) and pancreatic cancer (PC) mortality.

Methods

This analysis included 107 patients seen at Roswell Park Comprehensive Cancer Center diagnosed with PC between 1989 and 1998. Cox proportional hazards models were used to determine hazard ratios (HR) and 95% confidence intervals (CI) for PC mortality associated with self-reported pre-diagnostic RPI. Models were adjusted for known prognostic factors, including age, sex, stage at diagnosis, smoking status, and body mass index (BMI). Results were also stratified by sex, BMI, smoking status, histology, and treatment status.

Results

We observed a significant association between RPI and PC mortality in all patients (HR = 1.72, 95% CI = 1.06–2.79), as well as among overweight or obese patients (HR = 2.74, 95% 95% CI = 1.42–5.29), females (HR = 2.63; 95% CI, 1.08–6.39), and non-smokers (HR = 1.72; 95% CI, 1.02–2.89).

Conclusion

These results suggest that RPI prior to PC diagnosis is associated with a higher risk of death. Future studies with larger sample sizes are needed to explore whether this association varies across tumor histology.
Literature
2.
go back to reference Cannioto R, Etter JL, Guterman LB, Joseph JM, Gulati NR, Schmitt KL, et al. The association of lifetime physical inactivity with bladder and renal cancer risk: a hospital-based case-control analysis. Cancer Epidemiol. 2017;49:24–9.PubMedPubMedCentral Cannioto R, Etter JL, Guterman LB, Joseph JM, Gulati NR, Schmitt KL, et al. The association of lifetime physical inactivity with bladder and renal cancer risk: a hospital-based case-control analysis. Cancer Epidemiol. 2017;49:24–9.PubMedPubMedCentral
3.
go back to reference Cannioto R, Etter JL, LaMonte MJ, Ray AD, Joseph JM, Qassim EA, et al. Lifetime physical inactivity is associated with lung cancer risk and mortality. Cancer Treat Res Commun. 2018;14:37–45.PubMedPubMedCentral Cannioto R, Etter JL, LaMonte MJ, Ray AD, Joseph JM, Qassim EA, et al. Lifetime physical inactivity is associated with lung cancer risk and mortality. Cancer Treat Res Commun. 2018;14:37–45.PubMedPubMedCentral
4.
go back to reference Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, et al. Chronic recreational physical inactivity and epithelial ovarian cancer risk: evidence from the ovarian cancer association consortium. Cancer Epidemiol Biomark Prev. 2016;25(7):1114–24. Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, et al. Chronic recreational physical inactivity and epithelial ovarian cancer risk: evidence from the ovarian cancer association consortium. Cancer Epidemiol Biomark Prev. 2016;25(7):1114–24.
5.
go back to reference Cannioto RA, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the ovarian cancer association consortium. Br J Cancer. 2016;115(1):95–101.PubMedPubMedCentral Cannioto RA, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the ovarian cancer association consortium. Br J Cancer. 2016;115(1):95–101.PubMedPubMedCentral
6.
go back to reference Etter JL, Cannioto R, Soh KT, Alquassim E, Almohanna H, Dunbar Z, et al. Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: a case-control study. Leuk Res. 2018;69:7–11.PubMed Etter JL, Cannioto R, Soh KT, Alquassim E, Almohanna H, Dunbar Z, et al. Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: a case-control study. Leuk Res. 2018;69:7–11.PubMed
7.
go back to reference Godinho-Mota JCM, et al. Abdominal adiposity and physical inactivity are positively associated with breast cancer: a case-control study. Biomed Res Int. 2018;2018:7. Godinho-Mota JCM, et al. Abdominal adiposity and physical inactivity are positively associated with breast cancer: a case-control study. Biomed Res Int. 2018;2018:7.
8.
go back to reference Platek AJ, Cannioto RA, Etter JL, Kim J, Joseph JM, Gulati NR, et al. The association of lifetime physical inactivity with head and neck cancer: a hospital-based case-control analysis. Eur Arch Otorhinolaryngol. 2017;274(10):3773–80.PubMedPubMedCentral Platek AJ, Cannioto RA, Etter JL, Kim J, Joseph JM, Gulati NR, et al. The association of lifetime physical inactivity with head and neck cancer: a hospital-based case-control analysis. Eur Arch Otorhinolaryngol. 2017;274(10):3773–80.PubMedPubMedCentral
9.
go back to reference Silva DAS, Tremblay MS, Souza MFM, Mooney M, Naghavi M, Malta DC. Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990–2015): findings from the global burden of disease study. PLoS One. 2018;13(2):e0190943.PubMedPubMedCentral Silva DAS, Tremblay MS, Souza MFM, Mooney M, Naghavi M, Malta DC. Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990–2015): findings from the global burden of disease study. PLoS One. 2018;13(2):e0190943.PubMedPubMedCentral
10.
go back to reference Szender JB, Cannioto R, Gulati NR, Schmitt KL, Friel G, Minlikeeva A, et al. Impact of physical inactivity on risk of developing cancer of the uterine cervix: a case-control study. J Low Genit Tract Dis. 2016;20(3):230–3.PubMedPubMedCentral Szender JB, Cannioto R, Gulati NR, Schmitt KL, Friel G, Minlikeeva A, et al. Impact of physical inactivity on risk of developing cancer of the uterine cervix: a case-control study. J Low Genit Tract Dis. 2016;20(3):230–3.PubMedPubMedCentral
11.
go back to reference Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10–21.PubMed Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10–21.PubMed
12.
go back to reference McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8(3):205–11.PubMed McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8(3):205–11.PubMed
13.
go back to reference Dumith SC, Hallal PC, Reis RS, Kohl HW III. Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev Med. 2011;53(1–2):24–8.PubMed Dumith SC, Hallal PC, Reis RS, Kohl HW III. Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev Med. 2011;53(1–2):24–8.PubMed
14.
go back to reference Brooks JC, Shavelle RM, Vavra-Musser KN. Life expectancy in pancreatic neuroendocrine cancer. Clin Res Hepatol Gastroenterol. 2019;43(1):88–97.PubMed Brooks JC, Shavelle RM, Vavra-Musser KN. Life expectancy in pancreatic neuroendocrine cancer. Clin Res Hepatol Gastroenterol. 2019;43(1):88–97.PubMed
15.
go back to reference Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat Rev Rheumatol. 2015;11(2):86–97.PubMed Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat Rev Rheumatol. 2015;11(2):86–97.PubMed
16.
go back to reference Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, Kawai Y, et al. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut. 2013;62(6):882–9.PubMed Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, Kawai Y, et al. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut. 2013;62(6):882–9.PubMed
17.
go back to reference Dethlefsen C, Pedersen KS, Hojman P. Every exercise bout matters: linking systemic exercise responses to breast cancer control. Breast Cancer Res Treat. 2017;162(3):399–408.PubMed Dethlefsen C, Pedersen KS, Hojman P. Every exercise bout matters: linking systemic exercise responses to breast cancer control. Breast Cancer Res Treat. 2017;162(3):399–408.PubMed
18.
go back to reference Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2015;136(4):E197–202.PubMed Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2015;136(4):E197–202.PubMed
19.
go back to reference Idorn M, Hojman P. Exercise-dependent regulation of NK cells in cancer protection. Trends Mol Med. 2016;22(7):565–77.PubMed Idorn M, Hojman P. Exercise-dependent regulation of NK cells in cancer protection. Trends Mol Med. 2016;22(7):565–77.PubMed
20.
go back to reference Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23(3):554–62.PubMed Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23(3):554–62.PubMed
21.
go back to reference Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. Practical guide to measuring physical activity. J Acad Nutr Diet. 2014;114(2):199–208.PubMed Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. Practical guide to measuring physical activity. J Acad Nutr Diet. 2014;114(2):199–208.PubMed
22.
go back to reference Seicean A, Cainap C, Gulei I, Tantau M, Seicean R. Pain palliation by endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. J Gastrointestin Liver Dis. 2013;22(1):59–64.PubMed Seicean A, Cainap C, Gulei I, Tantau M, Seicean R. Pain palliation by endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. J Gastrointestin Liver Dis. 2013;22(1):59–64.PubMed
23.
go back to reference Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, Solheim TS. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Crit Rev Oncol Hematol. 2016;99:286–98.PubMed Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, Solheim TS. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Crit Rev Oncol Hematol. 2016;99:286–98.PubMed
Metadata
Title
Physical Inactivity and Pancreatic Cancer Mortality
Authors
Megha Pratapwar
Ashley E. Stenzel
Janine M. Joseph
Christos Fountzilas
John Lewis Etter
Jennifer M. Mongiovi
Rikki Cannioto
Kirsten B. Moysich
Publication date
01-09-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00441-9

Other articles of this Issue 3/2020

Journal of Gastrointestinal Cancer 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine